OLDSMAR, Fla., Oct. 14, 2010 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCBB:CCEL) (the “Company”), one of the world’s largest and most established family cord blood banks, today announced results for the third quarter ended August 31, 2010. Consolidated revenue for the third quarter of fiscal 2010 was $4.5 million compared to $4.6 million for the third quarter of fiscal 2009. The revenue for the third quarter of fiscal 2010 consisted of $4.2 million in processing and storage revenue and $334,000 in licensee income compared to $4.2 million in processing and storage revenue and $351,000 in licensee income in the same period in fiscal 2009. Licensee income for the three months ended August 31, 2010 consisted entirely of royalty income earned on the processing and storage of cord blood stem cell specimens in geographic areas where the Company has license agreements. Licensee income for the 2009 period consisted of $279,000 in royalty income earned on the processing and storage of specimens in geographical areas where the Company has license agreements and $75,000 related to an installment payment of a non-refundable up-front license fee from the licensee of the Company’s Celle program in India.
